{"id":4227,"date":"2001-03-17T15:47:16","date_gmt":"2001-03-17T14:47:16","guid":{"rendered":"http:\/\/moomango.co.uk\/htb\/?p=4227"},"modified":"2014-06-12T14:30:01","modified_gmt":"2014-06-12T14:30:01","slug":"roche-open-to-discuss-patent-rights-of-aids-drug-with-brazil","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/4227","title":{"rendered":"Roche open to discuss patent rights of AIDS drug with Brazil"},"content":{"rendered":"<p><strong>Roche Holding announced on Friday that it would be willing to confer with Brazil and with international trade organizations about the patent rights for its AIDS drug nelfinavir, following a threat from the nation that it would begin allowing generic firms to produce the drug if prices were not reduced.<\/strong><\/p>\n<p>A Roche spokesman said that the firm believes there is a need to explore, with the help of trade experts, the international patent rights and under what circumstances a country may overrule those rights. The United States has brought Brazil&#8217;s anti-AIDS program and its threat to the World Trade Organization, which will determine whether Brazil must amend its legislation.<\/p>\n<p>Reference:<\/p>\n<p>Agence France Presse<br \/>\n<a href=\"http:\/\/www.afp.com\">www.afp.com<\/a><\/p>\n<p>Source: CDC HIV\/STD\/TB Prevention News Update<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Roche Holding announced on Friday that it would be willing to confer with Brazil and with international trade organizations about the patent rights for its AIDS drug nelfinavir, following a threat from the nation that it would begin allowing generic &hellip;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[38],"tags":[],"class_list":["post-4227","post","type-post","status-publish","format-standard","hentry","category-treatment-access"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/4227","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=4227"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/4227\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=4227"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=4227"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=4227"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}